Related Experiment Video

Updated: Aug 15, 2026

Experimental Model to Evaluate Resolution of Pneumonia
09:49

Experimental Model to Evaluate Resolution of Pneumonia

Published on: February 17, 2023

[Atypical pneumonia]

Mária Szilasi1

  • 1Debreceni Egyetem, Orvos- es Egészségtudományi Centrum, Altalános Orvostudományi Kar, Tüdogyógyászati Klinika, Debrecen. mszilasi@jaguar.unideb.hu

Orvosi Hetilap
|September 28, 2005
PubMed

Insights

Atypical pneumonia cases are rising, posing diagnostic and treatment challenges. Early consideration of pathogens like Chlamydia, Mycoplasma, Coxiella, and Legionella can improve outcomes for lower respiratory tract infections.

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Epidemiology

Context:

  • Community-acquired pneumonia (CAP) diagnosis and treatment present challenges.
  • Increasing incidence of pneumonia caused by atypical pathogens is observed globally.
  • Atypical pathogens like Chlamydia pneumoniae, Chlamydia psittaci, Mycoplasma pneumoniae, Coxiella burnetti, and Legionella species are significant contributors to lower respiratory tract infections.

Purpose:

  • To provide a comprehensive overview of pneumonia caused by specific atypical pathogens.
  • To highlight the diagnostic and therapeutic difficulties associated with atypical pneumonia.
  • To emphasize the importance of considering these pathogens in lower respiratory tract infections.

Summary:

  • Presents an overview of pneumonia attributed to Chlamydia pneumoniae, Chlamydia psittaci, Mycoplasma pneumoniae, Coxiella burnetti, and Legionella species.
  • Discusses the challenges in diagnosing and treating lower respiratory tract infections caused by these atypical agents.
  • Underscores the need for increased clinical suspicion of atypical pathogens in pneumonia cases.

Impact:

  • Early and accurate diagnosis of atypical pneumonia can lead to timely and appropriate treatment.
  • Prompt initiation of treatment for atypical pneumonia can reduce the risk of severe outcomes.
  • Increased awareness of atypical pathogens may improve patient management and reduce morbidity and mortality associated with lower respiratory tract infections.

Related Concept Videos

Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include: